Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Veru Inc. (VERU)
USD2.42
+0.11 (+4.76%)
US NASDAQ Healthcare Biotechnology
Address
48 NW 25th Street 33127
Miami, FL, US
Miami, FL, US
CEO
Mitchell S. Steiner
Website
verupharma.com
IPO
1999-02-11
CIK 863894 ISIN US92536C2026
Description
Veru Inc. operates as a biopharmaceutical firm primarily dedicated to advancing novel therapeutic agents for various types of cancer. Commercially, Veru markets the FC2 internal condom, designed to offer dual protection against both unplanned pregnancies and the transmission of sexually transmitted infections. This product is distributed globally to a diverse clientele, including governmental health departments, UN organizations, non-profit entities, and commercial distributors. Its robust development pipeline features a range of investigational therapies, notably within oncology: Enobosarm, an orally administered selective androgen receptor agonist, is progressing through Phase III clinical trials for treating metastatic breast cancer that is AR+, ER+, and HER2-negative. Sabizabulin is undergoing Phase IIb studies for the same type of metastatic breast cancer. Furthermore, a combination therapy of Enobosarm with abemaciclib is in Phase III for AR+ ER+ HER2- metastatic breast cancer. For metastatic triple-negative breast cancer, Veru is exploring a combination of Sabizabulin (an oral targeted cytoskeleton disruptor) and Enobosarm (a selective androgen receptor agonist) in Phase II trials. The company's portfolio also extends to prostate cancer: Sabizabulin is in Phase II trials for metastatic castration and androgen receptor targeting agent-resistant prostate cancer. VERU-100, a GnRH antagonist peptide delivered via injection, is also in Phase II for advanced hormone-sensitive prostate cancer. Beyond oncology, Veru is investigating other conditions: Zuclomiphene Citrate is in Phase II for managing hot flashes. Sabizabulin has reached Phase III for treating SARS-CoV-2 in high-risk patients susceptible to acute respiratory distress syndrome. Additionally, the firm is developing a novel pharmaceutical formulation aimed at alleviating lower urinary tract symptoms associated with an enlarged prostate in men. Originally established as The Female Health Company in 1971, the corporation adopted the name Veru Inc. in July 2017. Its corporate headquarters are situated in Miami, Florida.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.42
+0.11 (+4.76%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
-1.13
Float Shares
13.99M
Free Float %
87.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.71% | +0.44% | -4.62% | -0.87% | -9.56% | +6.07% | -56.01% | -79.55% | -96.87% | -83.43% | -95.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (6 ratings, all time)
Buy
Price Targets & DCF
Current price
2.42
Low
3.00
+24.0%
Consensus
4.00
+65.3%
Median
4.00
+65.3%
High
5.00
+106.6%
DCF (Unlevered)
0.66
-72.6%
DCF (Levered)
0.87
-64.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 4 |
15.50
+540.5%
|
Quality scores
Altman Z-Score
-7.36
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-100.0%
-
EPS growth Biotechnology: +29.7%+61.8% ★ Q1'26: +79.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%— Q1'26: -15,810.5% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%— Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-1,135.3% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+8.6% Q1'26: +47.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.09× Q1'26: -0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 3 Rev. Ana. 1 EPS Ana. |
Sep 2027 2 Rev. Ana. 1 EPS Ana. |
Sep 2028 1 Rev. Ana. 2 EPS Ana. |
Sep 2029 1 Rev. Ana. 1 EPS Ana. |
Sep 2030 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
32.60M
est: 29.70M (+9.8%)
|
22.13M
est: 35.64M (-37.9%)
|
13.66M
est: 13.76M (-0.8%)
|
15.86M
est: 17.33M (-8.5%)
|
31.80M
est: 32.26M (-1.4%)
|
42.59M
est: 41.44M (+2.8%)
|
61.26M
est: 63.69M (-3.8%)
|
39.35M
est: 48.34M (-18.6%)
|
16.30M
est: 13.48M (+20.9%)
|
16.89M
est: 13.75M (+22.8%)
|
—
est: 2.75M (-100.0%)
|
2.67M
2.04M – 3.69M
-3.0% YoY
|
4.00M
2.84M – 5.57M
+50.0% YoY
|
50.00M
35.56M – 69.63M
+1,150.0% YoY
|
125.00M
88.89M – 174.07M
+150.0% YoY
|
—
— – —
-100.0% YoY
|
| EBITDA |
7.11M
est: -10.94M (+165.0%)
|
4.92M
est: -13.12M (+137.5%)
|
-8.12M
est: -5.07M (-60.3%)
|
-19.67M
est: -6.38M (-208.3%)
|
-7.14M
est: -11.88M (+39.9%)
|
-14.65M
est: -15.26M (+4.0%)
|
9.75M
est: -23.45M (+141.6%)
|
-79.23M
est: -17.80M (-345.1%)
|
-89.98M
est: -4.96M (-1,713.0%)
|
-36.20M
est: -5.06M (-615.3%)
|
-35.38M
est: -1.01M (-3,394.2%)
|
-981.8K
-1.36M – -752.0K
+3.0% YoY
|
-1.47M
-2.05M – -1.05M
-50.0% YoY
|
-18.41M
-25.64M – -13.09M
-1,150.0% YoY
|
-46.02M
-64.09M – -32.73M
-150.0% YoY
|
—
— – —
+100.0% YoY
|
| EBIT |
6.62M
est: -10.99M (+160.2%)
|
4.50M
est: -13.19M (+134.1%)
|
-8.60M
est: -5.09M (-68.9%)
|
-20.12M
est: -6.41M (-213.7%)
|
-7.62M
est: -11.94M (+36.2%)
|
-15.43M
est: -15.34M (-0.6%)
|
9.15M
est: -23.57M (+138.8%)
|
-79.44M
est: -17.89M (-344.0%)
|
-90.25M
est: -4.99M (-1,708.9%)
|
-36.47M
est: -5.09M (-616.8%)
|
-35.53M
est: -1.02M (-3,390.8%)
|
-987.0K
-1.36M – -756.0K
+3.0% YoY
|
-1.48M
-2.06M – -1.05M
-50.0% YoY
|
-18.51M
-25.77M – -13.16M
-1,150.0% YoY
|
-46.27M
-64.43M – -32.90M
-150.0% YoY
|
—
— – —
+100.0% YoY
|
| Net Income |
4.35M
est: 2.20M (+97.8%)
|
344.7K
est: 29.29M (-98.8%)
|
-6.61M
est: -24.90M (+73.4%)
|
-23.94M
est: -54.68M (+56.2%)
|
-12.02M
est: -27.83M (+56.8%)
|
-18.97M
est: -22.70M (+16.4%)
|
7.39M
est: 7.32M (+1.0%)
|
-83.78M
est: -123.76M (+32.3%)
|
-93.15M
est: -5.73M (-1,526.0%)
|
-37.80M
est: -43.65M (+13.4%)
|
-22.73M
est: -19.20M (-18.3%)
|
-18.53M
-26.21M – -10.84M
+3.5% YoY
|
-18.76M
-26.55M – -10.97M
-1.3% YoY
|
-11.79M
-16.26M – -7.32M
+37.2% YoY
|
-15.96M
-24.11M – -9.97M
-35.4% YoY
|
-14.65M
-22.12M – -9.15M
+8.3% YoY
|
| SGA |
12.13M
est: 42.95M (-71.8%)
|
8.75M
est: 51.53M (-83.0%)
|
11.07M
est: 19.90M (-44.4%)
|
14.82M
est: 25.06M (-40.9%)
|
14.35M
est: 46.65M (-69.2%)
|
14.50M
est: 59.92M (-75.8%)
|
20.67M
est: 92.10M (-77.6%)
|
43.17M
est: 69.90M (-38.2%)
|
48.06M
est: 19.49M (+146.6%)
|
31.18M
est: 19.88M (+56.9%)
|
19.94M
est: 3.98M (+401.5%)
|
3.86M
2.95M – 5.33M
-3.0% YoY
|
5.78M
4.11M – 8.05M
+50.0% YoY
|
72.30M
51.41M – 100.68M
+1,150.0% YoY
|
180.75M
128.53M – 251.71M
+150.0% YoY
|
—
— – —
-100.0% YoY
|
| EPS |
1.50
est: 0.15 (+900.0%)
|
0.10
est: 2.00 (-95.0%)
|
-2.48
est: -1.70 (-46.1%)
|
-4.44
est: -3.73 (-19.0%)
|
-1.90
est: -1.90 (+0.0%)
|
-2.84
est: -1.55 (-83.2%)
|
0.97
est: 0.50 (+94.0%)
|
-10.49
est: -8.45 (-24.1%)
|
-10.96
est: -0.37 (-2,890.9%)
|
-2.80
est: -2.98 (+6.0%)
|
-1.07
est: -1.13 (+5.3%)
|
-1.19
-1.79 – -0.74
-4.9% YoY
|
-1.20
-1.81 – -0.75
-1.3% YoY
|
-0.81
-1.11 – -0.50
+32.9% YoY
|
-1.09
-1.65 – -0.68
-35.4% YoY
|
-1.00
-1.51 – -0.62
+8.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-26.54M
OE per share TTM
-1.69
Owner's Yield
-59.13%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
11.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
18
Total invested
2.43M
Insider transactions (90d)
8
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Management, L.P. | 13.72M | 9.50% | — | 13.72M | — | — | IA, PN | Delaware | 2023-12-26 | ↗ |
| 2 | Adage Capital Partners GP, L.L.C. | 13.72M | 9.50% | — | 13.72M | — | — | OO | Delaware | 2023-12-26 | ↗ |
| 3 | Adage Capital Partners, L.P. | 13.72M | 9.50% | — | 13.72M | — | — | PN | Delaware | 2023-12-26 | ↗ |
| 4 | Phillip Gross | 13.72M | 9.50% | — | 13.72M | — | — | IN | Delaware | 2023-12-26 | ↗ |
| 5 | Robert Atchinson | 13.72M | 9.50% | — | 13.72M | — | — | IN | Delaware | 2023-12-26 | ↗ |
| 6 | (1) BlackRock, Inc. | 8.24M | 5.60% | 8.18M | — | — | — | HC | Delaware | 2024-11-08 | ↗ |
| 7 | Joseph Edelman | 7.86M | 9.70% | — | 7.86M | — | 7.86M | IN | — | 2023-02-14 | ↗ |
| 8 | Perceptive Advisors LLC | 7.86M | 9.70% | — | 7.86M | — | 7.86M | IA | — | 2023-02-14 | ↗ |
| 9 | Perceptive Life Sciences Master Fund, Ltd. | 7.86M | 9.70% | — | 7.86M | — | 7.86M | CO | — | 2023-02-14 | ↗ |
| 10 | Israel A. Englander | 7.60M | 5.20% | — | 7.60M | — | 7.60M | IN | Delaware | 2024-04-24 | ↗ |
| 11 | Millennium Group Management LLC | 7.60M | 5.20% | — | 7.60M | — | 7.60M | OO | Delaware | 2024-04-24 | ↗ |
| 12 | Millennium Management LLC | 7.60M | 5.20% | — | 7.60M | — | 7.60M | OO | Delaware | 2024-04-24 | ↗ |
| 13 | Morgan Stanley | 7.29M | 9.00% | — | 6.93M | — | 13.00 | HC, CO | Delaware. | 2023-02-10 | ↗ |
| 14 | Morgan Stanley Capital Services LLC | 6.88M | 8.50% | — | — | — | 13.00 | BD, CO | Delaware. | 2023-02-10 | ↗ |
| 15 | Frost Gamma Investments Trust | 5.00M | 6.10% | — | 5.00M | — | — | OO | United States | 2023-04-19 | ↗ |
| 16 | Phillip Frost, M.D. | 5.00M | 6.10% | — | 5.00M | — | — | IN | United States | 2023-04-19 | ↗ |
| 17 | The Vanguard Group - 23-1945930 | 3.03M | 3.79% | — | 101.5K | 2.88M | 147.7K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 18 | TAX # 742961140 | 2.96M | 10.26% | 2.96M | — | 2.96M | — | IA | USA, Texas | 2014-06-10 | ↗ |
| 19 | TAX # 46-5301261 | 2.88M | 9.96% | 2.88M | — | 2.88M | — | OO | USA, Texas | 2014-07-10 | ↗ |
| 20 | DUMAC, Inc | 1.75M | 6.10% | — | 1.75M | — | 1.75M | IA | North Carolina | 2014-03-06 | ↗ |
| 21 | Duke University | 1.75M | 6.10% | 801.4K | 947.1K | 801.4K | 947.1K | OO | North Carolina | 2014-03-06 | ↗ |
| 22 | The Duke Endowment | 476.3K | 1.70% | 476.3K | — | 476.3K | — | OO | North Carolina | 2014-03-06 | ↗ |
| 23 | Duke University Health System, Inc. | 250.8K | 0.90% | 250.8K | — | 250.8K | — | OO | North Carolina | 2014-03-06 | ↗ |
| 24 | Employees’ Retirement Plan of Duke University | 220.0K | 0.80% | 220.0K | — | 220.0K | — | EP | North Carolina | 2014-03-06 | ↗ |
| 25 | 13G/A | — | 0.00% | — | — | — | — | OO | North Carolina | 2015-02-17 | ↗ |
| 26 | Peter Kolchinsky | — | 0.00% | — | — | — | — | HC, IN | United States of America | 2022-11-14 | ↗ |
| 27 | RA Capital Healthcare Fund, L.P. | — | 0.00% | — | — | — | — | PN | United States of America | 2022-11-14 | ↗ |
| 28 | RA Capital Management, L.P. | — | 0.00% | — | — | — | — | IA, PN | United States of America | 2022-11-14 | ↗ |
| 29 | Rajeev Shah | — | 0.00% | — | — | — | — | HC, IN | United States of America | 2022-11-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
18
-36 vs prev Q
New positions
5
Closed positions
39
Increased
6
Reduced
4
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ALYESKA INVESTMENT GROUP, L.P. | 1.00M +1.0M (+100.0%) | 2.14M +2.1M (+100.0%) | 4.92% +4.923 pp | 0.01% +0.006 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 2 | VANGUARD GROUP INC | 634.0K -6.6K (-1.0%) | 1.36M -1.1M (-44.3%) | 3.12% -1.249 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 3 | OPPENHEIMER & CO INC | 197.9K +5.7K (+3.0%) | 423.5K -306.8K (-42.0%) | 1.35% +0.040 pp | 0.01% -0.003 pp | USD3.75 -42.9% | 2 qtrs — |
| 4 | GSA CAPITAL PARTNERS LLP | 195.7K +33.5K (+20.6%) | 419.0K -197.0K (-32.0%) | 1.34% +0.229 pp | 0.04% -0.015 pp | USD3.52 -39.2% | 2 qtrs — |
| 5 | MILLENNIUM MANAGEMENT LLC | 187.9K -43.7K (-18.9%) | 402.1K -477.9K (-54.3%) | 0.93% -0.655 pp | 0.00% 0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 155.4K -4.0K (-2.5%) | 332.6K -273.1K (-45.1%) | 0.76% -0.322 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 7 | SUMMIT FINANCIAL, LLC | 152.5K -11.4K (-6.9%) | 326.4K -296.3K (-47.6%) | 0.75% -0.367 pp | 0.00% -0.005 pp | USD3.80 -43.7% | 2 qtrs — |
| 8 | IKARIAN CAPITAL, LLC | 133.5K -9.0K (-6.3%) | 285.7K -255.9K (-47.2%) | 0.66% -0.315 pp | 0.02% -0.032 pp | USD3.80 -43.7% | 2 qtrs — |
| 9 | BLACKROCK, INC. | 114.4K +53.0 (+0.0%) | 244.7K -189.6K (-43.7%) | 0.56% -0.217 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 10 | CHOREO, LLC | 75.3K -139.0 (-0.2%) | 163.5K -123.3K (-43.0%) | 0.51% -0.001 pp | 0.00% -0.002 pp | USD3.80 -43.7% | 2 qtrs — |
| 11 | RAYMOND JAMES FINANCIAL INC | 74.6K +41.3K (+124.0%) | 159.6K +33.1K (+26.1%) | 0.37% +0.140 pp | 0.00% +0.000 pp | USD2.88 -25.7% | 2 qtrs — |
| 12 | NEWEDGE ADVISORS, LLC | 70.5K +56.1K (+388.7%) | 150.9K +96.1K (+175.2%) | 0.35% +0.249 pp | 0.00% +0.000 pp | USD2.48 -13.7% | 2 qtrs — |
| 13 | STATE STREET CORP | 55.0K +— (+0.0%) | 117.7K -91.3K (-43.7%) | 0.27% -0.104 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 14 | BLAIR WILLIAM & CO/IL | 48.0K +10.0K (+26.3%) | 102.7K -41.7K (-28.9%) | 0.24% -0.023 pp | 0.00% 0.000 pp | USD3.45 -38.0% | 2 qtrs — |
| 15 | ADAR1 CAPITAL MANAGEMENT, LLC | 35.0K +35.0K (+100.0%) | 74.9K +74.9K (+100.0%) | 0.17% +0.172 pp | 0.01% +0.006 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 16 | NORTHERN TRUST CORP | 33.6K +8.0K (+31.4%) | 71.9K -25.2K (-26.0%) | 0.17% -0.009 pp | 0.00% +0.000 pp | USD3.40 -37.1% | 2 qtrs — |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | 31.5K -9.0K (-22.2%) | 67.5K -86.6K (-56.2%) | 0.16% -0.121 pp | 0.00% -0.001 pp | USD3.80 -43.7% | 2 qtrs — |
| 18 | UBS GROUP AG | 29.5K -70.9K (-70.6%) | 63.2K -318.3K (-83.4%) | 0.15% -0.540 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 19 | JANE STREET GROUP, LLC | 21.3K +21.3K (+100.0%) | 45.6K +45.6K (+100.0%) | 0.10% +0.105 pp | 0.00% +0.000 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 20 | CITADEL ADVISORS LLC | 20.7K -4.2K (-16.8%) | 44.3K -50.2K (-53.1%) | 0.10% -0.068 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 21 | QUANTINNO CAPITAL MANAGEMENT LP | 20.0K +— (+0.0%) | 42.8K -33.2K (-43.7%) | 0.10% -0.038 pp | 0.00% 0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 22 | PRICE T ROWE ASSOCIATES INC /MD/ | 19.0K +— (+0.0%) | 41.0K -32.0K (-43.8%) | 0.09% -0.036 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17.5K -49.4K (-73.9%) | 37.4K -216.9K (-85.3%) | 0.09% -0.371 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 24 | GOLDMAN SACHS GROUP INC | 15.0K -536.0 (-3.5%) | 32.0K -26.9K (-45.6%) | 0.07% -0.032 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 25 | PVG ASSET MANAGEMENT CORP | 12.2K -146.6K (-92.3%) | 26.1K -577.4K (-95.7%) | 0.08% -1.000 pp | 0.06% -2.165 pp | USD3.80 -43.7% | 2 qtrs — |
| 26 | MARINER, LLC | 11.4K +11.4K (+100.0%) | 24.4K +24.4K (+100.0%) | 0.06% +0.056 pp | 0.00% +0.000 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 27 | INTEGRATED WEALTH CONCEPTS LLC | 11.3K +910.0 (+8.8%) | 24.1K -15.3K (-38.7%) | 0.06% -0.015 pp | 0.00% 0.000 pp | USD3.67 -41.7% | 2 qtrs — |
| 28 | ADVISOR GROUP HOLDINGS, INC. | 11.1K -13.4K (-54.7%) | 23.8K -56.5K (-70.4%) | 0.05% -0.113 pp | 0.00% 0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 29 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 10.0K +5.0 (+0.1%) | 21.4K -16.6K (-43.7%) | 0.05% -0.019 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 30 | ALLWORTH FINANCIAL LP | 7.8K +— (+0.0%) | 16.7K -13.0K (-43.7%) | 0.05% +0.000 pp | 0.00% 0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 31 | ROYAL BANK OF CANADA | 7.2K +6.4K (+803.9%) | 15.0K +12.0K (+400.0%) | 0.04% +0.030 pp | 0.00% +0.000 pp | USD2.32 -7.8% | 2 qtrs — |
| 32 | MORGAN STANLEY | 4.3K -13.7K (-76.3%) | 9.1K -59.2K (-86.6%) | 0.02% -0.102 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 33 | CHUNG WU INVESTMENT GROUP, LLC | 3.0K +3.0K (+100.0%) | 6.4K +6.4K (+100.0%) | 0.02% +0.021 pp | 0.01% +0.005 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 34 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.3K +1.3K (+100.0%) | 2.7K +2.7K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 35 | BANK OF AMERICA CORP /DE/ | 699.00 -17.3K (-96.1%) | 1.5K -66.9K (-97.8%) | 0.00% -0.119 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 36 | PNC FINANCIAL SERVICES GROUP, INC. | 500.00 +— (+0.0%) | 1.1K -830.0 (-43.7%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 37 | QUENT CAPITAL, LLC | 471.00 +228.0 (+93.8%) | 1.0K +85.0 (+9.2%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.99 -28.4% | 2 qtrs — |
| 38 | SBI SECURITIES CO., LTD. | 435.00 +— (+0.0%) | 931.00 -722.0 (-43.7%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 39 | WELLS FARGO & COMPANY/MN | 355.00 -544.0 (-60.5%) | 760.00 -2.7K (-77.8%) | 0.00% -0.004 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 40 | JPMORGAN CHASE & CO | 336.00 -200.0 (-37.3%) | 719.00 -1.3K (-64.7%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 41 | HARBOUR INVESTMENTS, INC. | 200.00 +— (+0.0%) | 428.00 -332.0 (-43.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 42 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 200.00 +— (+0.0%) | 428.00 -332.0 (-43.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 43 | JONES FINANCIAL COMPANIES LLLP | 166.00 +40.0 (+31.7%) | 355.00 -115.0 (-24.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.39 -36.9% | 2 qtrs — |
| 44 | TRUST CO OF TOLEDO NA /OH/ | 100.00 +— (+0.0%) | 214.00 -166.0 (-43.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 45 | LODESTONE WEALTH MANAGEMENT LLC | 100.00 +100.0 (+100.0%) | 214.00 +214.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.14 +0.0% | 1 qtrs NEW |
| 46 | MARSHALL & STERLING WEALTH ADVISORS INC. | 95.00 +— (+0.0%) | 203.00 -158.0 (-43.8%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 47 | NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 20.00 +— (+0.0%) | 43.00 -33.0 (-43.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.80 -43.7% | 2 qtrs — |
| 48 | BNP PARIBAS ARBITRAGE, SNC | 7.00 +— (+0.0%) | 15.00 -12.0 (-44.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.71 -42.3% | 2 qtrs — |
| 49 | OPTIVER HOLDING B.V. | 4.00 +— (+0.0%) | 9.00 -6.0 (-40.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.75 -42.9% | 2 qtrs — |
| 50 | CITIGROUP INC | 1.00 -58.0 (-98.3%) | 2.00 -222.0 (-99.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.00 -28.7% | 2 qtrs — |
| 51 | DANSKE BANK A/S | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -28.7% | 2 qtrs — |
| 52 | FMR LLC | — -1.1K (-100.0%) | — -4.1K (-100.0%) | 0.00% -0.007 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 53 | ENVESTNET ASSET MANAGEMENT INC | — -76.7K (-100.0%) | — -291.4K (-100.0%) | 0.00% -0.523 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 54 | GROUP ONE TRADING, L.P. | — -10.5K (-100.0%) | — -39.8K (-100.0%) | 0.00% -0.071 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 55 | 180 WEALTH ADVISORS, LLC | — -30.3K (-100.0%) | — -115.3K (-100.0%) | 0.00% -0.207 pp | 0.00% -0.014 pp | USD— | 2 qtrs SOLD |
| 56 | JACOBS LEVY EQUITY MANAGEMENT, INC | — -28.9K (-100.0%) | — -109.8K (-100.0%) | 0.00% -0.197 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 57 | SIGNATUREFD, LLC | — -300.0 (-100.0%) | — -1.1K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 20 qtrs SOLD |
| 58 | SIMPLEX TRADING, LLC | — -9.9K (-100.0%) | — -37.0K (-100.0%) | 0.00% -0.068 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 59 | SRS CAPITAL ADVISORS, INC. | — -1.0 (-100.0%) | — -3.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 60 | CETERA INVESTMENT ADVISERS | — -21.1K (-100.0%) | — -80.2K (-100.0%) | 0.00% -0.144 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 61 | CASSADAY & CO WEALTH MANAGEMENT LLC | — -12.4K (-100.0%) | — -47.1K (-100.0%) | 0.00% -0.085 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 62 | KEYSTONE FINANCIAL GROUP | — -32.0K (-100.0%) | — -18.6K (-100.0%) | 0.00% -0.218 pp | 0.00% -0.001 pp | USD— | 8 qtrs SOLD |
| 63 | TME FINANCIAL, INC. | — -10.9K (-100.0%) | — -41.4K (-100.0%) | 0.00% -0.074 pp | 0.00% -0.031 pp | USD— | 2 qtrs SOLD |
| 64 | BARCLAYS PLC | — -184.8K (-100.0%) | — -142.1K (-100.0%) | 0.00% -1.261 pp | 0.00% +0.000 pp | USD— | 7 qtrs SOLD |
| 65 | LPL FINANCIAL LLC | — -10.0K (-100.0%) | — -38.0K (-100.0%) | 0.00% -0.068 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 66 | TWO SIGMA SECURITIES, LLC | — -10.0K (-100.0%) | — -38.0K (-100.0%) | 0.00% -0.068 pp | 0.00% -0.006 pp | USD— | 2 qtrs SOLD |
| 67 | ATRIA INVESTMENTS, INC | — -25.3K (-100.0%) | — -96.3K (-100.0%) | 0.00% -0.173 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 68 | ADAGE CAPITAL PARTNERS GP, L.L.C. | — -100.0K (-100.0%) | — -380.0K (-100.0%) | 0.00% -0.682 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 69 | VSM WEALTH ADVISORY, LLC | — -10.0 (-100.0%) | — -38.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 70 | WEALTHSPIRE ADVISORS, LLC | — -122.0 (-100.0%) | — -464.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 71 | QUBE RESEARCH & TECHNOLOGIES LTD | — -18.3K (-100.0%) | — -69.4K (-100.0%) | 0.00% -0.125 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 137.8K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 366.4K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.9K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 5.2K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 387.74 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 897.0K | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.0K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.1K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 432.33 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 47.64 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
8
Sells
0
Shares acquired
1.49M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,491,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | STEINER MITCHELL SHUSTER | Director / Officer | A-Award | A | Common Stock Option | 604,000 | 2.25 | 1.36M | 604,000 | D | ↗ |
| 2026-05-04 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 100,000 | 2.25 | 225.0K | 100,000 | D | ↗ |
| 2026-05-04 | Lu Lucy | Director | A-Award | A | Common Stock Option | 104,000 | 2.25 | 234.0K | 104,000 | D | ↗ |
| 2026-05-04 | Katzovitz Loren Mark | Director | A-Award | A | Common Stock Option | 102,000 | 2.25 | 229.5K | 102,000 | D | ↗ |
| 2026-05-04 | Hyun Grace | Director | A-Award | A | Common Stock Option | 97,000 | 2.25 | 218.3K | 97,000 | D | ↗ |
| 2026-05-04 | Greco Michele | Officer | A-Award | A | Common Stock Option | 164,000 | 2.25 | 369.0K | 164,000 | D | ↗ |
| 2026-05-04 | FISCH HARRY | Director / Officer | A-Award | A | Common Stock Option | 160,000 | 2.25 | 360.0K | 160,000 | D | ↗ |
| 2026-05-04 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 160,000 | 2.25 | 360.0K | 160,000 | D | ↗ |
| 2025-12-05 | STEINER MITCHELL SHUSTER | Director / Officer | A-Award | A | Common Stock Option | 100,000 | 2.49 | 249.0K | 100,000 | D | ↗ |
| 2025-12-05 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 3,000 | 2.49 | 7.5K | 3,000 | D | ↗ |
| 2025-12-05 | Lu Lucy | Director | A-Award | A | Common Stock Option | 4,000 | 2.49 | 10.0K | 4,000 | D | ↗ |
| 2025-12-05 | Katzovitz Loren Mark | Director | A-Award | A | Common Stock Option | 6,000 | 2.49 | 14.9K | 6,000 | D | ↗ |
| 2025-12-05 | Hyun Grace | Director | A-Award | A | Common Stock Option | 6,000 | 2.49 | 14.9K | 6,000 | D | ↗ |
| 2025-12-05 | Greco Michele | Officer | A-Award | A | Common Stock Option | 27,000 | 2.49 | 67.2K | 27,000 | D | ↗ |
| 2025-12-05 | FISCH HARRY | Director / Officer | A-Award | A | Common Stock Option | 27,000 | 2.49 | 67.2K | 27,000 | D | ↗ |
| 2025-12-05 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 27,000 | 2.49 | 67.2K | 27,000 | D | ↗ |
| 2025-10-01 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 7,000 | 3.89 | 27.2K | 7,000 | D | ↗ |
| 2025-10-01 | Lu Lucy | Director | A-Award | A | Common Stock Option | 6,000 | 3.89 | 23.3K | 6,000 | D | ↗ |
| 2025-10-01 | Hyun Grace | Director | A-Award | A | Common Stock Option | 3,000 | 3.89 | 11.7K | 3,000 | D | ↗ |
| 2025-05-06 | STEINER MITCHELL SHUSTER | Director / Officer | A-Award | A | Common Stock Option | 378,000 | 0.50 | 189.8K | 378,000 | D | ↗ |
| 2025-05-06 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 15,000 | 0.50 | 7.5K | 15,000 | D | ↗ |
| 2025-05-06 | Lu Lucy | Director | A-Award | A | Common Stock Option | 30,000 | 0.50 | 15.1K | 30,000 | D | ↗ |
| 2025-05-06 | Katzovitz Loren Mark | Director | A-Award | A | Common Stock Option | 90,000 | 0.50 | 45.2K | 90,000 | D | ↗ |
| 2025-05-06 | Hyun Grace | Director | A-Award | A | Common Stock Option | 55,000 | 0.50 | 27.6K | 55,000 | D | ↗ |
| 2025-05-06 | Greco Michele | Officer | A-Award | A | Common Stock Option | 108,000 | 0.50 | 54.2K | 108,000 | D | ↗ |
| 2025-05-06 | FISCH HARRY | Director / Officer | A-Award | A | Common Stock Option | 104,000 | 0.50 | 52.2K | 104,000 | D | ↗ |
| 2025-05-06 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 104,000 | 0.50 | 52.2K | 104,000 | D | ↗ |
| 2025-03-13 | Katzovitz Loren Mark | Director | A-Award | A | Common Stock Option | 10,000 | 0.45 | 4.5K | 10,000 | D | ↗ |
| 2025-03-13 | Hyun Grace | Director | A-Award | A | Common Stock Option | 5,000 | 0.45 | 2.3K | 5,000 | D | ↗ |
| 2025-02-19 | Rankowitz Michael L | Director | P-Purchase | A | Common Stock | 54,721 | 0.58 | 31.9K | 250,000 | D | ↗ |
| 2025-02-18 | Rankowitz Michael L | Director | P-Purchase | A | Common Stock | 95,279 | 0.55 | 52.4K | 195,279 | D | ↗ |
| 2024-10-01 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 85,000 | 0.77 | 65.1K | 85,000 | D | ↗ |
| 2024-10-01 | Lu Lucy | Director | A-Award | A | Common Stock Option | 70,000 | 0.77 | 53.6K | 70,000 | D | ↗ |
| 2024-10-01 | Hyun Grace | Director | A-Award | A | Common Stock Option | 40,000 | 0.77 | 30.6K | 40,000 | D | ↗ |
| 2024-10-01 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 45,000 | 0.77 | 34.5K | 45,000 | D | ↗ |
| 2024-08-06 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 10,000 | 0.81 | 8.1K | 10,000 | — | ↗ |
| 2024-08-06 | Lu Lucy | Director | A-Award | A | Common Stock Option | 20,000 | 0.81 | 16.2K | 20,000 | — | ↗ |
| 2024-08-06 | Katzovitz Loren Mark | Director | A-Award | A | Common Stock Option | 80,000 | 0.81 | 64.9K | 80,000 | — | ↗ |
| 2024-08-06 | Hyun Grace | Director | A-Award | A | Common Stock Option | 40,000 | 0.81 | 32.4K | 40,000 | — | ↗ |
| 2024-08-06 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 30,000 | 0.81 | 24.3K | 30,000 | — | ↗ |
| 2024-08-01 | Katzovitz Loren Mark | Director | — | D | Common Stock | 0 | 0.00 | — | 224,000 | — | ↗ |
| 2024-05-24 | STEINER MITCHELL SHUSTER | Director / Officer | S-Sale | D | Common Stock | 63,379 | 1.23 | 78.1K | 6,942,709 | — | ↗ |
| 2024-05-24 | FISCH HARRY | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 1.25 | 5.0K | 774,736 | — | ↗ |
| 2024-05-24 | BARNETTE K GARY | Officer | P-Purchase | A | Common Stock | 5,000 | 1.34 | 6.7K | 5,000 | — | ↗ |
| 2024-05-23 | STEINER MITCHELL SHUSTER | Director / Officer | S-Sale | D | Common Stock | 300 | 1.35 | 405.00 | 7,006,088 | — | ↗ |
| 2024-05-22 | STEINER MITCHELL SHUSTER | Director / Officer | S-Sale | D | Common Stock | 6,504 | 1.39 | 9.0K | 7,006,388 | — | ↗ |
| 2024-05-17 | STEINER MITCHELL SHUSTER | Director / Officer | S-Sale | D | Common Stock | 28,066 | 1.32 | 37.0K | 7,012,892 | — | ↗ |
| 2024-05-16 | STEINER MITCHELL SHUSTER | Director / Officer | S-Sale | D | Common Stock | 59,788 | 1.41 | 84.1K | 7,040,958 | — | ↗ |
| 2024-05-15 | STEINER MITCHELL SHUSTER | Director / Officer | S-Sale | D | Common Stock | 84,021 | 1.50 | 125.8K | 7,100,746 | — | ↗ |
| 2024-05-15 | FISCH HARRY | Director / Officer | P-Purchase | A | Common Stock | 6,711 | 1.49 | 10.0K | 770,736 | — | ↗ |
| 2024-05-07 | STEINER MITCHELL SHUSTER | Director / Officer | A-Award | A | Common Stock Option | 376,000 | 1.63 | 612.9K | 376,000 | — | ↗ |
| 2024-05-07 | Greco Michele | Officer | A-Award | A | Common Stock Option | 106,000 | 1.63 | 172.8K | 106,000 | — | ↗ |
| 2024-05-07 | FISCH HARRY | Director / Officer | A-Award | A | Common Stock Option | 102,000 | 1.63 | 166.3K | 102,000 | — | ↗ |
| 2024-05-07 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 102,000 | 1.63 | 166.3K | 102,000 | — | ↗ |
| 2023-10-02 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 90,000 | 0.73 | 65.7K | 90,000 | — | ↗ |
| 2023-10-02 | Lu Lucy | Director | A-Award | A | Common Stock Option | 80,000 | 0.73 | 58.4K | 80,000 | — | ↗ |
| 2023-10-02 | Hyun Grace | Director | A-Award | A | Common Stock Option | 60,000 | 0.73 | 43.8K | 60,000 | — | ↗ |
| 2023-10-02 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 70,000 | 0.73 | 51.1K | 70,000 | — | ↗ |
| 2023-05-09 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 374,000 | 1.37 | 512.4K | 374,000 | — | ↗ |
| 2023-05-09 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 5,000 | 1.37 | 6.9K | 5,000 | — | ↗ |
| 2023-05-09 | Lu Lucy | Director | A-Award | A | Common Stock Option | 10,000 | 1.37 | 13.7K | 10,000 | — | ↗ |
| 2023-05-09 | Hyun Grace | Director | A-Award | A | Common Stock Option | 20,000 | 1.37 | 27.4K | 20,000 | — | ↗ |
| 2023-05-09 | Greco Michele | Officer | A-Award | A | Common Stock Option | 104,000 | 1.37 | 142.5K | 104,000 | — | ↗ |
| 2023-05-09 | FISCH HARRY | Director / Officer | A-Award | A | Common Stock Option | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2023-05-09 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 15,000 | 1.37 | 20.6K | 15,000 | — | ↗ |
| 2023-05-09 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2022-11-02 | STEINER MITCHELL SHUSTER | Officer | A-Award | A | Common Stock Option | 372,000 | 0.00 | — | 372,000 | — | ↗ |
| 2022-11-02 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 95,000 | 0.00 | — | 95,000 | — | ↗ |
| 2022-11-02 | Lu Lucy | Director | A-Award | A | Common Stock Option | 90,000 | 0.00 | — | 90,000 | — | ↗ |
| 2022-11-02 | Hyun Grace | Director | A-Award | A | Common Stock Option | 80,000 | 0.00 | — | 80,000 | — | ↗ |
| 2022-11-02 | Greco Michele | Officer | A-Award | A | Common Stock Option | 102,000 | 0.00 | — | 102,000 | — | ↗ |
| 2022-11-02 | FISCH HARRY | Officer | A-Award | A | Common Stock Option | 98,000 | 0.00 | — | 98,000 | — | ↗ |
| 2022-11-02 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 85,000 | 0.00 | — | 85,000 | — | ↗ |
| 2022-11-02 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 98,000 | 0.00 | — | 98,000 | — | ↗ |
| 2022-08-15 | Eisenberger Mario | Director | S-Sale | D | Common Stock | 100,000 | 20.04 | 2.00M | 0 | — | ↗ |
| 2022-04-22 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 300,000 | 11.21 | 3.36M | 300,000 | — | ↗ |
| 2022-04-22 | Greco Michele | Officer | A-Award | A | Common Stock Option | 100,000 | 11.21 | 1.12M | 100,000 | — | ↗ |
| 2022-04-22 | FISCH HARRY | Officer | A-Award | A | Common Stock Option | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2022-04-22 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 200,000 | 11.21 | 2.24M | 200,000 | — | ↗ |
| 2022-03-29 | Hyun Grace | Director | A-Award | A | Common Stock Option | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2021-11-03 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 360,000 | 8.35 | 3.01M | 360,000 | — | ↗ |
| 2021-11-03 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 70,000 | 8.35 | 584.5K | 70,000 | — | ↗ |
| 2021-11-03 | Lu Lucy | Director | A-Award | A | Common Stock Option | 70,000 | 8.35 | 584.5K | 70,000 | — | ↗ |
| 2021-11-03 | Hyun Grace | Director | A-Award | A | Common Stock Option | 55,000 | 8.35 | 459.3K | 55,000 | — | ↗ |
| 2021-11-03 | Greco Michele | Officer | A-Award | A | Common Stock Option | 128,400 | 8.35 | 1.07M | 128,400 | — | ↗ |
| 2021-11-03 | FISCH HARRY | Director / 10% Owner | A-Award | A | Common Stock Option | 133,200 | 8.35 | 1.11M | 133,200 | — | ↗ |
| 2021-11-03 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 70,000 | 8.35 | 584.5K | 70,000 | — | ↗ |
| 2021-11-03 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 134,800 | 8.35 | 1.13M | 134,800 | — | ↗ |
| 2021-08-17 | Lu Lucy | Director | P-Purchase | A | Common Stock | 4,800 | 6.78 | 32.5K | 9,800 | — | ↗ |
| 2021-06-16 | FISCH HARRY | Director / 10% Owner | S-Sale | D | Common Stock | 100,000 | 8.35 | 835.3K | 764,025 | — | ↗ |
| 2021-05-14 | Lu Lucy | Director | A-Award | A | Common Stock Option | 70,000 | 7.56 | 529.2K | 70,000 | — | ↗ |
| 2021-03-23 | Hyun Grace | Director | A-Award | A | Common Stock Option | 5,000 | 13.05 | 65.3K | 5,000 | — | ↗ |
| 2021-03-10 | Hyun Grace | Director | P-Purchase | A | Common Stock | 3,500 | 14.09 | 49.3K | 14,790 | — | ↗ |
| 2021-02-12 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 20.88 | 417.7K | 190,000 | — | ↗ |
| 2020-12-16 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 250,000 | 9.69 | 2.42M | 7,184,767 | — | ↗ |
| 2020-12-16 | BARNETTE K GARY | Officer | S-Sale | D | Common Stock | 100,000 | 10.65 | 1.06M | 0 | — | ↗ |
| 2020-11-13 | Socorro Jesus | Director | A-Award | A | Common Stock Option | 75,000 | 2.75 | 206.3K | 75,000 | — | ↗ |
| 2020-11-13 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 360,000 | 2.75 | 990.0K | 360,000 | — | ↗ |
| 2020-11-13 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 70,000 | 2.75 | 192.5K | 70,000 | — | ↗ |
| 2020-11-13 | Hyun Grace | Director | A-Award | A | Common Stock Option | 50,000 | 2.75 | 137.5K | 50,000 | — | ↗ |
| 2020-11-13 | Greco Michele | Officer | A-Award | A | Common Stock Option | 109,500 | 2.75 | 301.1K | 109,500 | — | ↗ |
| 2020-11-13 | FISCH HARRY | Director / 10% Owner | A-Award | A | Common Stock Option | 105,000 | 2.75 | 288.8K | 105,000 | — | ↗ |
| 2020-11-13 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 70,000 | 2.75 | 192.5K | 70,000 | — | ↗ |
| 2020-11-13 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 112,500 | 2.75 | 309.4K | 112,500 | — | ↗ |
| 2020-08-26 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 2.76 | 13.8K | 864,025 | — | ↗ |
| 2020-08-24 | Greco Michele | Officer | P-Purchase | A | Common Stock | 5,000 | 2.65 | 13.2K | 96,178 | — | ↗ |
| 2020-08-11 | Hyun Grace | Director | — | D | Common Stock | 0 | 0.00 | — | 11,290 | — | ↗ |
| 2020-02-21 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 4.47 | 4.5K | 859,025 | — | ↗ |
| 2020-02-20 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 4.51 | 4.5K | 858,025 | — | ↗ |
| 2020-02-19 | Socorro Jesus | Director | P-Purchase | A | Common Stock | 5,000 | 4.27 | 21.4K | 32,500 | — | ↗ |
| 2019-12-19 | Socorro Jesus | Director | P-Purchase | A | Common Stock | 5,000 | 2.80 | 14.0K | 27,500 | — | ↗ |
| 2019-12-05 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 16,590 | 2.22 | 36.8K | 7,434,767 | — | ↗ |
| 2019-12-04 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 8,410 | 2.20 | 18.5K | 7,451,357 | — | ↗ |
| 2019-11-14 | Socorro Jesus | Director | A-Award | A | Common Stock Option | 55,000 | 1.92 | 105.6K | 55,000 | — | ↗ |
| 2019-11-14 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 350,000 | 1.92 | 672.0K | 350,000 | — | ↗ |
| 2019-11-14 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 55,000 | 1.92 | 105.6K | 55,000 | — | ↗ |
| 2019-11-14 | Greco Michele | Officer | A-Award | A | Common Stock Option | 94,800 | 1.92 | 182.0K | 94,800 | — | ↗ |
| 2019-11-14 | FISCH HARRY | Director / 10% Owner | A-Award | A | Common Stock Option | 123,552 | 1.92 | 237.2K | 123,552 | — | ↗ |
| 2019-11-14 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 55,000 | 1.92 | 105.6K | 55,000 | — | ↗ |
| 2019-11-14 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 105,000 | 1.92 | 201.6K | 105,000 | — | ↗ |
| 2019-11-07 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,382 | 2.00 | 14.7K | 7,463,263 | — | ↗ |
| 2019-11-06 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 17,618 | 1.99 | 35.0K | 7,470,645 | — | ↗ |
| 2019-10-11 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,897 | 2.01 | 15.9K | 7,488,263 | — | ↗ |
| 2019-10-10 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,600 | 2.10 | 13.9K | 7,496,160 | — | ↗ |
| 2019-10-09 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,339 | 2.11 | 2.8K | 7,502,760 | — | ↗ |
| 2019-10-04 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,829 | 2.11 | 8.1K | 7,504,099 | — | ↗ |
| 2019-10-03 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,260 | 2.11 | 11.1K | 7,507,928 | — | ↗ |
| 2019-10-02 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,075 | 2.12 | 10.8K | 7,513,188 | — | ↗ |
| 2019-09-06 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,890 | 1.92 | 13.2K | 7,518,263 | — | ↗ |
| 2019-09-05 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,610 | 1.92 | 10.7K | 7,525,153 | — | ↗ |
| 2019-09-04 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 17,500 | 1.94 | 34.0K | 7,530,763 | — | ↗ |
| 2019-09-03 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 1.93 | 19.3K | 857,025 | — | ↗ |
| 2019-08-30 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 4,000 | 1.97 | 7.9K | 847,025 | — | ↗ |
| 2019-08-29 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 7,000 | 1.92 | 13.4K | 843,025 | — | ↗ |
| 2019-08-20 | Greco Michele | Officer | P-Purchase | A | Common Stock | 20,000 | 1.84 | 36.7K | 91,178 | — | ↗ |
| 2019-08-12 | Socorro Jesus | Director | P-Purchase | A | Common Stock | 10,000 | 1.95 | 19.5K | 22,500 | — | ↗ |
| 2019-08-07 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 30,000 | 2.26 | 67.8K | 7,548,263 | — | ↗ |
| 2019-07-03 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 2.25 | 45.0K | 7,578,263 | — | ↗ |
| 2019-06-05 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 1.98 | 39.6K | 7,598,263 | — | ↗ |
| 2019-05-13 | Socorro Jesus | Director | A-Award | A | Common Stock Option | 55,000 | 1.60 | 88.0K | 55,000 | — | ↗ |
| 2019-05-13 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 215,600 | 1.60 | 345.0K | 215,600 | — | ↗ |
| 2019-05-13 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 55,000 | 1.60 | 88.0K | 55,000 | — | ↗ |
| 2019-05-13 | Greco Michele | Officer | A-Award | A | Common Stock Option | 92,100 | 1.60 | 147.4K | 92,100 | — | ↗ |
| 2019-05-13 | FISCH HARRY | Director / 10% Owner | A-Award | A | Common Stock Option | 99,000 | 1.60 | 158.4K | 99,000 | — | ↗ |
| 2019-05-13 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 55,000 | 1.60 | 88.0K | 55,000 | — | ↗ |
| 2019-05-13 | BARNETTE K GARY | Officer | A-Award | A | Common Stock Option | 99,000 | 1.60 | 158.4K | 99,000 | — | ↗ |
| 2019-05-01 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 1.43 | 28.5K | 7,618,263 | — | ↗ |
| 2019-04-10 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,686 | 1.51 | 11.6K | 7,638,263 | — | ↗ |
| 2019-04-05 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,100 | 1.44 | 14.5K | 7,645,949 | — | ↗ |
| 2019-04-04 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,854 | 1.44 | 8.4K | 7,656,049 | — | ↗ |
| 2019-04-03 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,360 | 1.47 | 9.3K | 7,661,903 | — | ↗ |
| 2019-03-26 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 5,000 | 1.50 | 7.5K | 5,000 | — | ↗ |
| 2019-03-20 | Todd Charles T Jr | Officer | — | D | Common Stock Options | 280,000 | 2.17 | 607.6K | 0 | — | ↗ |
| 2019-03-20 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 49,899 | 1.53 | 76.1K | 7,668,263 | — | ↗ |
| 2019-03-15 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 1.47 | 4.4K | 836,025 | — | ↗ |
| 2019-03-13 | FISCH HARRY | Director | P-Purchase | A | Common Stock | 3,500 | 1.47 | 5.1K | 833,025 | — | ↗ |
| 2019-03-06 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 1.43 | 4.3K | 829,525 | — | ↗ |
| 2019-03-05 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 3,500 | 1.47 | 5.1K | 826,525 | — | ↗ |
| 2019-03-01 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,496 | 1.50 | 5.2K | 7,714,666 | — | ↗ |
| 2019-02-28 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,500 | 1.50 | 2.3K | 7,718,162 | — | ↗ |
| 2019-02-27 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 3,400 | 1.39 | 4.7K | 823,025 | — | ↗ |
| 2019-02-26 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 1.27 | 6.4K | 819,625 | — | ↗ |
| 2019-02-25 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 1.32 | 4.0K | 814,625 | — | ↗ |
| 2019-02-22 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 6,000 | 1.30 | 7.8K | 811,625 | — | ↗ |
| 2019-02-21 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 1.35 | 6.8K | 805,625 | — | ↗ |
| 2019-02-19 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 1.36 | 6.8K | 800,625 | — | ↗ |
| 2019-02-15 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 13,681 | 1.36 | 18.7K | 795,625 | — | ↗ |
| 2019-02-13 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,650 | 1.52 | 7.1K | 7,719,662 | — | ↗ |
| 2019-02-08 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,955 | 1.50 | 10.4K | 7,724,312 | — | ↗ |
| 2019-02-07 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 300 | 1.50 | 450.00 | 7,731,267 | — | ↗ |
| 2019-02-06 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,200 | 1.51 | 4.8K | 7,731,567 | — | ↗ |
| 2019-01-24 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,400 | 1.33 | 5.9K | 7,734,767 | — | ↗ |
| 2019-01-23 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,768 | 1.34 | 17.2K | 7,739,167 | — | ↗ |
| 2019-01-18 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,832 | 1.34 | 17.2K | 7,751,935 | — | ↗ |
| 2019-01-02 | Todd Charles T Jr | Officer | A-Award | A | Common Stock Option | 42,226 | 1.40 | 59.1K | 42,226 | — | ↗ |
| 2018-12-18 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 30,000 | 1.42 | 42.7K | 781,944 | — | ↗ |
| 2018-12-18 | BARNETTE K GARY | Officer | P-Purchase | A | Common Stock | 50,000 | 1.51 | 75.5K | 100,000 | — | ↗ |
| 2018-12-17 | BARNETTE K GARY | Officer | P-Purchase | A | Common Stock | 50,000 | 1.41 | 70.7K | 50,000 | — | ↗ |
| 2018-12-14 | Greco Michele | Officer | — | D | Common Stock Option | 78,508 | 1.22 | 95.8K | 0 | — | ↗ |
| 2018-12-11 | STEINER MITCHELL SHUSTER | Director / Officer / 10% Owner | A-Award | A | Common Stock Option | 125,802 | 1.38 | 173.6K | 125,802 | — | ↗ |
| 2018-12-11 | Greco Michele | Officer | A-Award | A | Common Stock Option | 83,025 | 1.38 | 114.6K | 83,025 | — | ↗ |
| 2018-12-11 | FISCH HARRY | Director | A-Award | A | Common Stock Option | 37,395 | 1.38 | 51.6K | 37,395 | — | ↗ |
| 2018-12-04 | Greco Michele | Officer | — | D | Common Stock Option | 105,209 | 1.05 | 110.5K | 0 | — | ↗ |
| 2018-10-31 | BETHUNE DAVID R | Director | M-Exempt | A | Common Stock | 140,000 | 0.00 | — | 575,982 | — | ↗ |
| 2018-09-06 | Socorro Jesus | Director | P-Purchase | A | Common Stock | 5,400 | 1.89 | 10.2K | 12,500 | — | ↗ |
| 2018-09-06 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 8,000 | 1.88 | 15.1K | 751,944 | — | ↗ |
| 2018-09-05 | FISCH HARRY | Director / 10% Owner | P-Purchase | A | Common Stock | 7,800 | 1.91 | 14.9K | 743,944 | — | ↗ |
| 2018-09-04 | BARNETTE K GARY | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-08-17 | Rankowitz Michael L | Director | A-Award | A | Common Stock Option | 5,000 | 2.08 | 10.4K | 5,000 | — | ↗ |
| 2018-08-17 | Eisenberger Mario | Director | A-Award | A | Common Stock Option | 5,000 | 2.08 | 10.4K | 5,000 | — | ↗ |
| 2018-08-02 | Greco Michele | Officer | — | D | Common Stock Option | 44,792 | 1.20 | 53.8K | 0 | — | ↗ |
| 2018-08-02 | Getzenberg Robert | Officer | — | D | Common Stock Option | 300,000 | 1.20 | 360.0K | 0 | — | ↗ |
| 2018-06-28 | PARRISH O B | Director | G-Gift | D | Common Stock | 47,000 | 0.00 | — | 797,849 | — | ↗ |
| 2018-05-02 | Socorro Jesus | Director | A-Award | A | Common Stock Option | 55,000 | 1.89 | 104.0K | 55,000 | — | ↗ |
| 2018-05-02 | STEINER MITCHELL SHUSTER | Officer / 10% Owner | A-Award | A | Common Stock Option | 210,800 | 1.89 | 398.4K | 210,800 | — | ↗ |
| 2018-05-02 | PARRISH O B | Director | A-Award | A | Common Stock Option | 40,000 | 1.89 | 75.6K | 40,000 | — | ↗ |
| 2018-05-02 | Lu Lucy | Director | A-Award | A | Common Stock Option | 50,000 | 1.89 | 94.5K | 50,000 | — | ↗ |
| 2018-05-02 | Greco Michele | Officer | A-Award | A | Common Stock Option | 90,000 | 1.89 | 170.1K | 90,000 | — | ↗ |
| 2018-05-02 | Getzenberg Robert | Officer | A-Award | A | Common Stock Option | 99,000 | 1.89 | 187.1K | 99,000 | — | ↗ |
| 2018-05-02 | Frank Mary Margaret | Director | A-Award | A | Common Stock Option | 50,000 | 1.89 | 94.5K | 50,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
16.05M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 836.2K | — | — | 163.3K | 636.2K | 14.0K | 1.65M | 9.90% | ↗ |
| 2 | 2025 | K. Gary Barnette, Chief Scientific Officer | 615.6K | — | — | 44.9K | 266.5K | 14.0K | 941.0K | 4.77% | ↗ |
| 3 | 2025 | Harry Fisch Vice Chairman and Chief Corporate Officer | 505.6K | — | — | 44.9K | 218.9K | — | 769.4K | 5.84% | ↗ |
| 4 | 2024 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 804.0K | — | — | 516.8K | 656.4K | — | 1.98M | 26.14% | ↗ |
| 5 | 2024 | K. Gary Barnette, Chief Scientific Officer | 591.9K | — | — | 140.2K | 270.6K | — | 1.00M | 13.98% | ↗ |
| 6 | 2024 | Harry Fisch Vice Chairman and Chief Corporate Officer | 486.2K | — | — | 140.2K | 222.3K | — | 848.6K | 16.52% | ↗ |
| 7 | 2023 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 865.5K | — | — | 3.83M | — | 19.8K | 4.71M | 81.22% | ↗ |
| 8 | 2023 | K. Gary Barnette, Chief Scientific Officer | 656.5K | — | — | 1.01M | — | 19.8K | 1.69M | 59.90% | ↗ |
| 9 | 2023 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 473.9K | — | — | 1.05M | — | 19.8K | 1.55M | 68.05% | ↗ |
| 10 | 2023 | Harry Fisch Vice Chairman and Chief Corporate Officer | 500.6K | — | — | 1.01M | — | — | 1.51M | 66.87% | ↗ |
| 11 | 2022 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 760.7K | 15.0K | — | 4.58M | 726.0K | 18.3K | 6.10M | 75.07% | ↗ |
| 12 | 2022 | K. Gary Barnette, Chief Scientific Officer | 553.8K | 15.0K | — | 2.46M | 317.0K | 18.3K | 3.37M | 73.14% | ↗ |
| 13 | 2022 | Harry Fisch, Vice Chairman and Chief Corporate Officer | 467.4K | 15.0K | — | 2.45M | 226.4K | — | 3.16M | 77.58% | ↗ |
| 14 | 2022 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 445.8K | 5.0K | — | 1.57M | 213.2K | 18.3K | 2.25M | 69.74% | ↗ |
| 15 | 2021 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 618.0K | — | — | 578.8K | 790.3K | 18.0K | 2.01M | 28.87% | ↗ |
| 16 | 2021 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 382.5K | — | — | 176.0K | 263.8K | 13.3K | 835.7K | 21.07% | ↗ |
| 17 | 2021 | K. Gary Barnette, Chief Scientific Officer | 397.5K | — | — | 180.9K | 226.7K | 12.5K | 817.6K | 22.12% | ↗ |
| 18 | 2020 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 501.9K | — | — | 388.7K | 367.7K | 5.0K | 1.26M | 30.77% | ↗ |
| 19 | 2020 | K. Gary Barnette, Chief Scientific Officer | 350.0K | — | — | 116.6K | 145.2K | 11.8K | 623.6K | 18.70% | ↗ |
| 20 | 2020 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 316.1K | — | — | 105.3K | 116.4K | 11.3K | 549.0K | 19.18% | ↗ |
| 21 | 2019 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 392.1K | — | — | 208.4K | 199.8K | — | 800.2K | 26.04% | ↗ |
| 22 | 2019 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 392.1K | — | — | 208.4K | 199.8K | — | 800.2K | 26.04% | ↗ |
| 23 | 2019 | K. Gary Barnette, Chief Scientific Officer | 330.0K | — | — | 95.7K | 137.8K | 13.7K | 577.2K | 16.58% | ↗ |
| 24 | 2019 | K. Gary Barnette, Chief Scientific Officer | 330.0K | — | — | 95.7K | 137.8K | 13.7K | 577.2K | 16.58% | ↗ |
| 25 | 2019 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 306.9K | — | — | 89.0K | 114.9K | 12.3K | 523.1K | 17.01% | ↗ |
| 26 | 2019 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 306.9K | — | — | 89.0K | 114.9K | 12.3K | 523.1K | 17.01% | ↗ |
| 27 | 2019 | Charles T. Todd, Jr., Former CEO of FHC Division | 142.6K | 5.0K | — | 35.5K | — | 144.0K | 327.1K | 10.85% | ↗ |
| 28 | 2018 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 383.3K | — | — | 231.2K | 125.8K | — | 740.3K | 31.23% | ↗ |
| 29 | 2018 | Charles T. Todd, Jr., Former CEO of FHC Division | 164.6K | — | — | 359.1K | — | — | 523.6K | 68.57% | ↗ |
| 30 | 2018 | Michele Greco, Chief Financial Officer and Chief Administrative Officer | 269.2K | — | — | 160.9K | 83.0K | 8.7K | 521.8K | 30.83% | ↗ |
| 31 | 2018 | Michele Greco Chief Financial Officer and Chief Administrative Officer | 269.2K | — | — | 160.9K | 83.0K | 8.7K | 521.8K | 30.83% | ↗ |
| 32 | 2018 | Brian Groch, Former Chief Commercial Officer | 197.6K | — | — | 29.5K | — | 242.2K | 469.4K | 6.29% | ↗ |
| 33 | 2018 | Robert Getzenberg, Former Chief Scientific Officer | 338.2K | — | — | 108.6K | — | 12.8K | 459.5K | 23.63% | ↗ |
| 34 | 2018 | K. Gary Barnette, Chief Scientific Officer | 26.1K | 50.0K | — | 324.6K | — | — | 400.7K | 81.00% | ↗ |
| 35 | 2018 | K. Gary Barnette, Chief Scientific Officer | 26.1K | 50.0K | — | 324.6K | — | — | 400.7K | 81.00% | ↗ |
| 36 | 2017 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 406.3K | — | — | 229.4K | 188.4K | — | 824.1K | 27.84% | ↗ |
| 37 | 2017 | Mitchell S. Steiner, Chairman, President and Chief Executive Officer | 406.3K | — | — | 199.5K | 188.4K | — | 794.2K | 25.12% | ↗ |
| 38 | 2017 | Daniel Haines, | 270.8K | — | — | 229.4K | 80.9K | 8.1K | 589.3K | 38.93% | ↗ |
| 39 | 2017 | Brian Groch, Former Chief Commercial Officer | 225.0K | — | — | 196.7K | 97.3K | 6.8K | 525.7K | 37.41% | ↗ |
| 40 | 2017 | Brian Groch, Former Chief Commercial Officer | 225.0K | — | — | 171.0K | 97.3K | 6.8K | 500.1K | 34.19% | ↗ |
| 41 | 2017 | Michele Greco Executive Vice President of Finance and Chief Administrative Officer | 286.6K | — | — | 29.4K | 78.5K | 8.4K | 402.9K | 7.29% | ↗ |
| 42 | 2017 | Michele Greco Chief Financial Officer and Chief Administrative Officer | 229.2K | — | — | 25.5K | 78.5K | 6.7K | 340.0K | 7.51% | ↗ |
| 43 | 2017 | O.B. Parrish, Former Chairman and Chief Executive Officer | 14.3K | — | — | — | — | — | 14.3K | 0.00% | ↗ |
| 44 | 2016 | Michele Greco Executive Vice President of Finance and Chief Administrative Officer | 217.4K | — | 39.8K | 11.7K | — | 6.9K | 275.8K | 18.67% | ↗ |
| 45 | 2016 | Michele Greco, Executive Vice President of Finance and Former Chief Financial Officer | 217.4K | — | 39.8K | 11.7K | — | 6.9K | 275.8K | 18.67% | ↗ |
| 46 | 2016 | Susan Ostrowski, Former Executive Vice President of Sales and Marketing | 106.0K | — | — | — | — | 139.1K | 245.1K | 0.00% | ↗ |
| 47 | 2016 | Martin Tayler, Executive Vice President of Global Operations | 155.3K | — | 12.5K | — | — | 25.2K | 193.0K | 6.48% | ↗ |
| 48 | 2016 | O.B. Parrish, Former Chairman and Chief Executive Officer | 169.9K | — | — | — | — | 5.3K | 175.2K | 0.00% | ↗ |
| 49 | 2015 | Karen King, former Chief Executive Officer and President | 295.5K | — | — | — | — | 221.1K | 516.6K | 0.00% | ↗ |
| 50 | 2015 | O.B. Parrish, Former Chairman and Chief Executive Officer | 169.9K | — | 134.0K | — | — | 8.7K | 312.6K | 42.86% | ↗ |
| 51 | 2015 | O.B. Parrish, Chairman and Chief Executive Officer | 169.9K | — | 134.0K | — | — | 8.7K | 312.6K | 42.86% | ↗ |
| 52 | 2015 | Michele Greco, Executive Vice President and Chief Financial Officer | 215.3K | — | — | — | 70.7K | 6.7K | 292.7K | 0.00% | ↗ |
| 53 | 2015 | Michele Greco, Executive Vice President of Finance and Former Chief Financial Officer | 215.3K | — | — | — | 70.7K | 6.7K | 292.7K | 0.00% | ↗ |
| 54 | 2015 | Susan Ostrowski, Executive Vice President of Sales and Marketing | 212.0K | — | — | — | 70.7K | 4.5K | 287.2K | 0.00% | ↗ |
| 55 | 2015 | Susan Ostrowski, Former Executive Vice President of Sales and Marketing | 212.0K | — | — | — | 70.7K | 4.5K | 287.2K | 0.00% | ↗ |
| 56 | 2015 | Martin Tayler, Executive Vice President of Global Operations | 168.5K | — | — | — | 70.7K | 22.8K | 261.9K | 0.00% | ↗ |
| 57 | 2014 | Karen King, Chief Executive Officer and President | 245.5K | — | 401.5K | — | — | 18.0K | 665.0K | 60.38% | ↗ |
| 58 | 2014 | Karen King, former Chief Executive Officer and President | 245.5K | — | 401.5K | — | — | 18.0K | 665.0K | 60.38% | ↗ |
| 59 | 2014 | Michele Greco, Executive Vice President and Chief Financial Officer | 207.5K | — | 78.7K | — | — | 6.5K | 292.7K | 26.89% | ↗ |
| 60 | 2014 | Michele Greco, Executive Vice President of Finance and Former Chief Financial Officer | 207.5K | — | 78.7K | — | — | 6.5K | 292.7K | 26.89% | ↗ |
| 61 | 2014 | Susan Ostrowski, Executive Vice President of Sales and Marketing | 101.4K | — | 119.0K | — | — | — | 220.3K | 53.99% | ↗ |
| 62 | 2014 | Susan Ostrowski Executive Vice President of Sales and Marketing | 101.4K | — | 119.0K | — | — | — | 220.3K | 53.99% | ↗ |
| 63 | 2014 | Susan Ostrowski, Former Executive Vice President of Sales and Marketing | 101.4K | — | 119.0K | — | — | — | 220.3K | 53.99% | ↗ |
| 64 | 2014 | O.B. Parrish, Former Chairman and Chief Executive Officer | 169.9K | — | — | — | — | 13.1K | 183.0K | 0.00% | ↗ |
| 65 | 2014 | O.B. Parrish, Chairman and Chief Executive Officer | 169.9K | — | — | — | — | 13.1K | 183.0K | 0.00% | ↗ |
| 66 | 2014 | Michael Pope, former Vice President, U.K. and Malaysian Operations | 137.7K | — | — | — | — | 35.3K | 173.0K | 0.00% | ↗ |
| 67 | 2014 | Martin Tayler, Executive Vice President of Global Operations | 8.2K | — | 112.0K | — | — | — | 120.2K | 93.16% | ↗ |
| 68 | 2014 | O.B. Parrish, Chairman and former Chief Executive Officer and President | 50.7K | — | — | — | — | 4.1K | 54.8K | 0.00% | ↗ |
| 69 | 2013 | Michele Greco, Vice President and Chief Financial Officer | 178.8K | 24.0K | 138.0K | — | — | 6.3K | 347.1K | 39.75% | ↗ |
| 70 | 2013 | Michele Greco, Executive Vice President and Chief Financial Officer | 178.8K | 24.0K | 138.0K | — | — | 6.3K | 347.1K | 39.75% | ↗ |
| 71 | 2013 | O.B. Parrish, Chairman and Former Chief Executive Officer and Acting President | 168.2K | 105.0K | — | — | — | 19.5K | 292.7K | 0.00% | ↗ |
| 72 | 2013 | O.B. Parrish, Chairman and former Chief Executive Officer and President | 168.2K | 105.0K | — | — | — | 19.5K | 292.7K | 0.00% | ↗ |
| 73 | 2013 | O.B. Parrish, Chairman and Chief Executive Officer | 168.2K | 105.0K | — | — | — | 19.5K | 292.7K | 0.00% | ↗ |
| 74 | 2013 | Michael Pope, former Vice President, U.K. and Malaysian Operations | 198.0K | 29.0K | — | — | — | 32.5K | 259.5K | 0.00% | ↗ |
| 75 | 2013 | Michael Pope, Vice President, U.K. and Malaysian Operations | 198.0K | 29.0K | — | — | — | 32.5K | 259.5K | 0.00% | ↗ |
| 76 | 2013 | Donna Felch, Former Vice President and Chief Financial Officer | 56.7K | — | — | — | — | 1.4K | 58.2K | 0.00% | ↗ |
| 77 | 2013 | Susan Ostrowski Executive Vice President of Sales and Marketing | — | — | — | — | — | — | — | — | ↗ |
| 78 | 2013 | Martin Tayler, Executive Vice President of Global Operations | — | — | — | — | — | — | — | — | ↗ |
| 79 | 2013 | Karen King, Chief Executive Officer and President | — | — | — | — | — | — | — | — | ↗ |
| 80 | 2013 | Susan Ostrowski, Executive Vice President of Sales and Marketing | — | — | — | — | — | — | — | — | ↗ |
| 81 | 2013 | Karen King, former Chief Executive Officer and President | — | — | — | — | — | — | — | — | ↗ |
| 82 | 2012 | O.B. Parrish, Chairman and former Chief Executive Officer and President | 164.9K | — | — | — | 910.0K | 19.5K | 1.09M | 0.00% | ↗ |
| 83 | 2012 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 164.9K | — | — | — | 910.0K | 19.5K | 1.09M | 0.00% | ↗ |
| 84 | 2012 | O.B. Parrish, Chairman and Former Chief Executive Officer and Acting President | 164.9K | — | — | — | 910.0K | 19.5K | 1.09M | 0.00% | ↗ |
| 85 | 2012 | Mike Pope, Vice President of the Company and General Manager of Female Health Company (UK) Plc | 194.8K | — | — | — | 350.0K | 32.9K | 577.7K | 0.00% | ↗ |
| 86 | 2012 | Michael Pope, former Vice President, U.K. and Malaysian Operations | 194.8K | — | — | — | 350.0K | 32.9K | 577.7K | 0.00% | ↗ |
| 87 | 2012 | Michael Pope, Vice President, U.K. and Malaysian Operations | 194.8K | — | — | — | 350.0K | 32.9K | 577.7K | 0.00% | ↗ |
| 88 | 2012 | Donna Felch, Former Vice President and Chief Financial Officer | 205.7K | — | — | — | 350.0K | 14.1K | 569.9K | 0.00% | ↗ |
| 89 | 2012 | Susan Ostrowski Executive Vice President of Sales and Marketing | — | — | — | — | — | — | — | — | ↗ |
| 90 | 2012 | Karen King, Chief Executive Officer and President | — | — | — | — | — | — | — | — | ↗ |
| 91 | 2012 | Michele Greco, Executive Vice President and Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 92 | 2012 | Michele Greco, Vice President and Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 93 | 2011 | Mike Pope, Vice President of the Company and General Manager of Female Health Company (UK) Plc | 189.5K | — | 261.0K | — | — | 32.6K | 483.1K | 54.02% | ↗ |
| 94 | 2011 | Michael Pope, Vice President, U.K. and Malaysian Operations | 189.5K | — | 261.0K | — | — | 32.6K | 483.1K | 54.02% | ↗ |
| 95 | 2011 | Mike Pope, Vice President of the Company and General Manager of Female Health Company (UK) Plc. | 182.6K | — | — | — | — | 32.6K | 476.2K | 0.00% | ↗ |
| 96 | 2011 | Donna Felch, Vice President and Chief Financial Officer | 198.4K | — | 261.0K | — | — | 10.7K | 470.1K | 55.52% | ↗ |
| 97 | 2011 | Donna Felch, Former Vice President and Chief Financial Officer | 199.0K | — | 261.0K | — | — | 6.0K | 466.0K | 56.01% | ↗ |
| 98 | 2011 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 159.9K | — | 261.0K | — | — | 19.5K | 440.5K | 59.26% | ↗ |
| 99 | 2011 | O.B. Parrish, Chairman and Former Chief Executive Officer and Acting President | 159.9K | — | 261.0K | — | — | 19.5K | 440.5K | 59.26% | ↗ |
| 100 | 2011 | Michele Greco, Vice President and Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 101 | 2010 | Donna Felch, Chief Financial Officer and Vice President | 195.9K | — | — | — | — | — | 209.6K | 0.00% | ↗ |
| 102 | 2010 | Donna Felch, Vice President and Chief Financial Officer | 195.9K | — | — | — | — | 13.6K | 209.6K | 0.00% | ↗ |
| 103 | 2010 | Mike Pope, Vice President of the Company and General Manager of Female Health Company (UK) Plc | 177.1K | — | — | — | — | 29.8K | 206.9K | 0.00% | ↗ |
| 104 | 2010 | Mike Pope, Vice President of the Company and General Manager of Female Health Company (UK) Plc. | 177.1K | — | — | — | — | 29.8K | 206.9K | 0.00% | ↗ |
| 105 | 2010 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 177.1K | — | — | — | — | — | 206.9K | 0.00% | ↗ |
| 106 | 2010 | Donna Felch, Former Vice President and Chief Financial Officer | 195.9K | — | — | — | — | 10.4K | 206.4K | 0.00% | ↗ |
| 107 | 2010 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 157.5K | — | — | — | — | 19.5K | 177.1K | 0.00% | ↗ |
| 108 | 2009 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 152.8K | 31.3K | — | — | 555.5K | 25.4K | 765.0K | 0.00% | ↗ |
| 109 | 2009 | Donna Felch, Chief Financial Officer and Vice President | 191.2K | — | — | — | — | — | 545.0K | 0.00% | ↗ |
| 110 | 2009 | Donna Felch, Vice President and Chief Financial Officer | 191.2K | — | 189.6K | — | 151.5K | 12.6K | 545.0K | 34.79% | ↗ |
| 111 | 2009 | Mike Pope, Vice President of the Company and General Manager of Female Health Company (UK) Plc. | 171.9K | — | 189.6K | — | 151.5K | 28.9K | 541.9K | 34.99% | ↗ |
| 112 | 2009 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 171.9K | — | — | — | — | — | 541.9K | 0.00% | ↗ |
| 113 | 2008 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 145.1K | 93.8K | 66.1K | — | 366.0K | 22.1K | 693.0K | 9.53% | ↗ |
| 114 | 2008 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 211.7K | — | 15.2K | — | 122.0K | 34.5K | 383.4K | 3.96% | ↗ |
| 115 | 2008 | Donna Felch, Chief Financial Officer and Vice President | 185.0K | — | 15.2K | — | 122.0K | 9.5K | 331.7K | 4.58% | ↗ |
| 116 | 2007 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 140.0K | — | 245.4K | — | — | 22.1K | 407.4K | 60.22% | ↗ |
| 117 | 2007 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 140.0K | — | — | — | — | — | 407.4K | 0.00% | ↗ |
| 118 | 2007 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 227.0K | 34.0K | — | — | — | — | 345.3K | 0.00% | ↗ |
| 119 | 2007 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 227.0K | — | 50.6K | — | — | 33.6K | 311.3K | 16.26% | ↗ |
| 120 | 2007 | Donna Felch, Chief Financial Officer and Vice President | 175.0K | 34.0K | — | — | — | — | 271.3K | 0.00% | ↗ |
| 121 | 2007 | Donna Felch, Chief Financial Officer and Vice President | 175.0K | — | 56.9K | — | — | 5.5K | 237.3K | 23.97% | ↗ |
| 122 | 2006 | Mary Ann Leeper, Ph. D., Senior Strategic Adviser | 204.2K | — | — | — | — | — | 204.2K | 0.00% | ↗ |
| 123 | 2006 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 168.8K | — | — | — | — | — | 168.8K | 0.00% | ↗ |
| 124 | 2006 | Donna Felch, Chief Financial Officer and Vice President | 108.2K | 25.1K | — | — | — | — | 133.3K | 0.00% | ↗ |
| 125 | 2006 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 110.8K | — | — | — | — | — | 110.8K | 0.00% | ↗ |
| 126 | 2005 | Mary Ann Leeper, Ph.D., President and Chief Operating Officer | 250.0K | — | 37.5K | — | — | — | 287.5K | 13.04% | ↗ |
| 127 | 2005 | Mary Ann Leeper, Ph. D., Senior Strategic Adviser | 250.0K | — | — | — | — | — | 250.0K | 0.00% | ↗ |
| 128 | 2005 | Michael Pope, Vice President and General Manager of The Female Health Company (UK) Plc. | 160.3K | — | 7.5K | — | — | — | 167.8K | 4.47% | ↗ |
| 129 | 2005 | O.B. Parrish, Chairman and Chief Executive Officer | 90.0K | — | 75.0K | — | — | — | 165.0K | 45.45% | ↗ |
| 130 | 2005 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 160.3K | — | — | — | — | — | 160.3K | 0.00% | ↗ |
| 131 | 2005 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 90.0K | — | — | — | — | — | 90.0K | 0.00% | ↗ |
| 132 | 2004 | Mary Ann Leeper, Ph.D., President and Chief Operating Officer | 250.0K | — | 47.0K | — | — | — | 297.0K | 15.82% | ↗ |
| 133 | 2004 | O.B. Parrish, Chairman and Chief Executive Officer | 90.0K | — | 117.5K | — | — | — | 207.5K | 56.63% | ↗ |
| 134 | 2004 | Michael Pope, Vice President and General Manager of The Female Health Company (UK) Plc. | 155.1K | — | 11.8K | — | — | — | 166.8K | 7.04% | ↗ |
| 135 | 2004 | Michael Pope, Vice President and General Manager of the Female Health Company (UK) Plc. | 155.1K | — | — | — | — | — | 155.1K | 0.00% | ↗ |
| 136 | 2004 | O.B. Parrish, Chairman, Chief Executive Officer and Acting President | 90.0K | — | — | — | — | — | 90.0K | 0.00% | ↗ |
| 137 | 2003 | Mary Ann Leeper, Ph.D. President and Chief Operating Officer | 225.0K | — | 46.2K | 790.0K | — | — | 271.2K | 308.33% | ↗ |
| 138 | 2003 | Mary Ann Leeper, Ph.D., President and Chief Operating Officer | 225.0K | — | 46.2K | 790.0K | — | — | 271.2K | 308.33% | ↗ |
| 139 | 2003 | O.B. Parrish, Chairman and Chief Executive Officer | 90.0K | — | 66.0K | 464.0K | — | — | 156.0K | 339.74% | ↗ |
| 140 | 2003 | O.B. Parrish Chairman and Chief Executive Officer | 90.0K | — | 66.0K | 464.0K | — | — | 156.0K | 339.74% | ↗ |
| 141 | 2003 | Michael Pope Vice President and General Manager of The Female Health Company (UK) Plc. | 136.8K | 16.5K | — | 370.0K | — | — | 153.3K | 241.43% | ↗ |
| 142 | 2003 | Michael Pope, Vice President and General Manager of The Female Health Company (UK) Plc. | 121.9K | 16.5K | — | 370.0K | — | — | 138.4K | 267.41% | ↗ |
| 143 | 2002 | Mary Ann Leeper, Ph.D. President and Chief Operating Officer | 225.0K | — | 404.9K | — | — | — | 629.9K | 64.28% | ↗ |
| 144 | 2002 | Mary Ann Leeper, Ph.D., President and Chief Operating Officer | 225.0K | — | 404.9K | — | — | — | 629.9K | 64.28% | ↗ |
| 145 | 2002 | O.B. Parrish, Chairman and Chief Executive Officer | 90.0K | — | 237.8K | — | — | — | 327.8K | 72.54% | ↗ |
| 146 | 2002 | O.B. Parrish Chairman and Chief Executive Officer | 90.0K | — | 237.8K | — | — | — | 327.8K | 72.54% | ↗ |
| 147 | 2002 | Michael Pope Vice President and General Manager of The Female Health Company (UK) Plc. | 121.9K | — | 189.6K | — | — | — | 311.5K | 60.87% | ↗ |
| 148 | 2002 | Michael Pope, Vice President and General Manager of The Female Health Company (UK) Plc. | 121.9K | — | 189.6K | — | — | — | 311.5K | 60.87% | ↗ |
| 149 | 2001 | Mary Ann Leeper, Ph.D. President and Chief Operating Officer | 225.0K | — | — | — | — | — | 225.0K | 0.00% | ↗ |
| 150 | 2001 | Michael Pope Vice President and General Manager of The Female Health Company (UK) Plc. | 118.9K | — | — | — | — | — | 118.9K | 0.00% | ↗ |
| 151 | 2001 | O.B. Parrish Chairman and Chief Executive Officer | 90.0K | — | — | — | — | — | 90.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mitchell S. Steiner | Chairman, President & Chief Executive Officer | 1M | — |
| K. Gary Barnette | Chief Scientific Officer | 896.1K | — |
| Harry Fisch | Vice Chairman & Chief Corporate Officer | 724.5K | — |
| Michele Greco | Chief Financial Officer & Chief Administrative Officer | 493.7K | female |
| Martin Tayler | Executive Vice President of FC2 Global Operations | 180.5K | male |
| Samuel Fisch | Executive Director of Investor Relations & Corporate Communications | — | male |
| Gary Bird | Executive Vice President of Quality & Regulatory Affairs | — | — |
| Kevin J. Gilbert | Executive Vice President of Corporate Development | — | male |
| Philip R. Greenberg | Executive VP, General Counsel & Secretary | — | male |
| Domingo Rodriguez | Executive Vice President of Global Clinical Operations | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VERU
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
